HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 BlockadeDavid Woods, Jeffrey S. Weber|Cancer Immunology Research|2015Cited by 433
Predictors of responses to immune checkpoint blockade in advanced melanomaNicolas Jacquelot, Laurence Zitvogel, David Woods et al.|Nature Communications|2017Cited by 201
C reactive protein impairs adaptive immunity in immune cells of patients with melanomaTatsuya Yoshida, Jeffrey S. Weber, Junya Ichikawa et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 96